Iridex (IRIX) Income from Discontinued Operations (2012)
Iridex's (IRIX) quarterly Income from Discontinued Operations came in at 149000.0 in Q4 2012, up 178.42% quarter-over-quarter from 190000.0 in Q3 2012.
Iridex (IRIX) Income from Discontinued Operations (2012) Analysis & Trends
Iridex's Income from Discontinued Operations history runs 1 years deep, the most recent figure standing at 149000.0 for Q4 2012.
- On a quarterly basis, Income from Discontinued Operations changed N/A year-over-year to 149000.0 in Q4 2012; TTM through Sep 2013 was 149000.0, a N/A change from a year earlier, with the FY2012 full-year figure at 264000.0, down 156.29% from the prior year.
- Income from Discontinued Operations advanced to 149000.0 in Q4 2012 per IRIX's latest filing, from 190000.0 in the prior quarter.
- Across five years, Income from Discontinued Operations topped out at 149000.0 in Q4 2012 and bottomed at 190000.0 in Q3 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.35 Bn | 180.06 Bn | 6.27 Bn | - |
| 2 | Stryker | 132.18 Bn | 129.31 Bn | 3.81 Bn | - |
| 3 | Medtronic | 111.47 Bn | 102.25 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 68.97 Bn | 67.51 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.51 Bn | 44.83 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.00 Bn | 27.88 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.78 Bn | 26.49 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 28.00 Bn | 27.42 Bn | - | - |
| 9 | Koninklijke Philips | 24.26 Bn | 21.22 Bn | 2.01 Bn | - |
| 10 | Iridex | 15.30 Mn | 10.70 Mn | 4.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 29, 2012 | 149,000.00 |
| Sep 29, 2012 | -190,000.00 |
| Jun 30, 2012 | -61,000.00 |
| Mar 31, 2012 | -162,000.00 |